InvestorsObserver
×
News Home

Is China Biologic Products Holdings Inc (CBPO) Stock About to Get Hot Wednesday?

Wednesday, May 27, 2020 01:50 PM | InvestorsObserver Analysts

Mentioned in this article

Is China Biologic Products Holdings Inc (CBPO) Stock About to Get Hot Wednesday?

The market has been down on China Biologic Products Holdings Inc (CBPO) stock recently. CBPO gets a Bearish score from InvestorsObserver's Stock Sentiment Indicator.

Sentiment Score - ,bearish

China Biologic Products Holdings Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on CBPO!

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.

Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.

InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.

Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With CBPO Stock Today?

China Biologic Products Holdings Inc (CBPO) stock is trading at $107.88 as of 1:47 PM on Wednesday, May 27, a rise of $1.54, or 1.45% from the previous closing price of $106.34. The stock has traded between $105.78 and $107.97 so far today. Volume today is below average. So far 23,853 shares have traded compared to average volume of 71,789 shares.

To see InvestorsObserver's Sentiment Score for China Biologic Products Holdings Inc click here.

More About China Biologic Products Holdings Inc

China Biologic Products Holdings Inc is a biopharmaceutical company principally engaged in the research, development, manufacturing and sales of human plasma-based products in China. The company operates its business through two majority owned subsidiaries, Shandong Taibang and Guizhou Taibang. China Biologic's product pipeline includes a variety of dosages across multiple product categories. Its principal products are human albumin and immunoglobulin for intravenous injection. All of the company's products are prescription medicines administered in the form of injections. China Biologic's sales model focuses on direct sales to hospitals and inoculation centers and is complemented by distributor sales.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App